Peer-reviewed veterinary case report
Epimesatines P-S: Four Undescribed Flavonoids from <i>Epimedium sagittatum</i> Maxim. and Their Cytotoxicity Activities.
- Year:
- 2024
- Authors:
- Xie SS et al.
- Affiliation:
- School of Pharmacy · China
Abstract
In this study, four previously undescribed flavonoids, named epimesatines P (<b>1</b>), Q (<b>2</b>), R (<b>3</b>), and S (<b>4</b>), were isolated from the aerial parts of <i>Epimedium sagittatum</i> Maxim. Their structures and absolute configurations were confirmed via spectroscopic analyses, quantum chemical electronic circular dichroism (ECD) calculations, Mo<sub>2</sub>(OAc)<sub>4</sub>-induced ECD, and Rh<sub>2</sub>(OCOCF<sub>3</sub>)<sub>4</sub>-induced ECD experiments. Epimesatines Q and R were characterized by the presence of furan rings. A cytotoxicity assay demonstrated that epimesatines P-S exhibited significant inhibitory effects on the viability of MCF-7 human breast cancer cells, with IC<sub>50</sub> values ranging from 1.27 to 50.3 μM. Notably, epimesatines Q and R exhibited superior efficacy against MCF-7 cells compared to epimesatines P and S, suggesting that the presence of furan rings may enhance their activity against MCF-7 cells. Specifically, epimesatine Q displayed a more potent inhibitory effect at 1.27 μM compared to a positive control, docetaxel, which had an IC<sub>50</sub> of 2.13 μM, highlighting its potential as a therapeutic agent for breast cancer. Importantly, none of the tested compounds exhibited obvious toxicity toward MCF-10A human breast epithelial cells. Furthermore, compounds <b>1</b>, <b>3</b>, and <b>4</b> were found to significantly inhibit the expression of sphingosine kinase 1 (Sphk1) in MCF-7 cells.
Find similar cases for your pet
PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.
Search related cases →Original publication: https://europepmc.org/article/MED/39407639